Results 221 to 230 of about 8,311 (256)

Redoubling efforts to sustain seasonal malaria chemoprevention

The Lancet Child & Adolescent Health, 2022
Perpetua, Uhomoibhi, Keziah Laurencia, Malm, Idrissa, Cisse, Hamza, Dzibo, Abena, Poku-Awuku, André-Marie, Tchouatieu, Peter Ehizibue, Olumese, Suzanne, Van Hulle, Lia, Florey, Scott, Filler, Jaya, Banerji   +10 more
openaire   +2 more sources

Pharmacometric evaluation of sulfadoxine-pyrimethamine- amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda.

Clinical Infectious Diseases
BACKGROUND Seasonal malaria chemoprevention (SMC) using monthly sulfadoxine-pyrimethamine-amodiaquine (SPAQ) is being deployed East Africa, where antimalarial drug resistance levels are high. Dihydroartemisinin-piperaquine (DP) is a potential alternative.
C. Bonnington, A. Nuwa, K. Theiss-Nyland, R. Kajubi, M. Kamya, J. Nankabirwa, C. Ebong, J. Nabakooza, J. Opigo, David Salandindi, Musa Odongo, C. Sararat, J. Watson, K. Suwannasin, S. Proux, Urairat Koesukwiwat, J. Tarning, M. Imwong, James Tibenderana, F. Nosten, N. White   +20 more
semanticscholar   +1 more source

Assessment of Factors Influencing Effective Implementation of Health Projects in Humanitarian Settings: A Case of Seasonal Malaria Chemoprevention Project by Malaria Consortium in Northern Bahrelgazal State, South Sudan

International Journal of Research Publication and Reviews
Background: In humanitarian settings, the successful implementation of health projects faces numerous challenges. This study focuses on the Seasonal Malaria Chemoprevention (SMC) project by Malaria Consortium in Northern Bahrelgazal State, South Sudan ...
Abubaker Rom Deng, Abdulrahman Muhammad
semanticscholar   +1 more source

Is Seasonal Malaria Chemoprevention with Sulfadoxine-Pyrimethamine/Amodiaquine Appropriate in East Africa?

Clinical Infectious Diseases
Philip J. Rosenthal
semanticscholar   +2 more sources

Moving seasonal malaria chemoprevention out of its geographical isolation

The Lancet Infectious Diseases, 2023
Ally, Olotu, Jörg J, Möhrle
openaire   +2 more sources

Seasonal malaria chemoprevention: closing the know–do gap

The Lancet, 2020
Elizabeth A, Ashley, Adoke, Yeka
openaire   +2 more sources

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon

Wellcome Open Research
Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months ...
Pacome V K Tchuenkam, L. Ngum, I. Ali, J. Chedjou, Akindeh M. Nji, P. Netongo, Randolph A. Ngwafor, P. T. N. Niba, Calvino Tah, W. D. Nana, Germaine Ekoyol, Jude D Bigoga, Dorothy F. Ashu, Christopher B. Tume, Wilfried F. Mbacham   +14 more
semanticscholar   +1 more source

Co-evolution of immunity and seasonal influenza viruses

Nature Reviews Microbiology, 2023
Alvin X Han, Colin A Russell
exaly  

Faculty Opinions recommendation of Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2022
openaire   +1 more source

Seasonal malaria chemoprevention in the Sahel

The Lancet Infectious Diseases, 2017
openaire   +2 more sources